Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation.
- 1 December 1991
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 54 (12) , 1061-1062
- https://doi.org/10.1136/jnnp.54.12.1061
Abstract
The effectiveness of intranasal neostigmine (9.3-13.8 mg) was tested in 20 subjects with myasthenia gravis, classified as Osserman grades 2A and 2B. In all cases the drug produced significant clinical and electromyographic improvement. No side effects were reported during the treatment.Keywords
This publication has 6 references indexed in Scilit:
- Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravisZeitschrift für Neurologie, 1988
- Effect of Bile Salts on Nasal Permeability In VitroJournal of Pharmaceutical Sciences, 1987
- Topical therapy for oropharyngeal symptoms of myasthenia gravisAnnals of Neurology, 1986
- ELECTRICAL TESTING IN MYASTHENIA GRAVIS*Annals of the New York Academy of Sciences, 1971
- Electrical and mechanical responses of normal and myasthenic muscleBrain Research, 1968